FDA.reportPublic FDA data

Application 211323

Type
ANDA
Sponsor
CADILA PHARMS LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001VENLAFAXINE HYDROCHLORIDEVENLAFAXINE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORALEQ 75MG BASENoNo
002VENLAFAXINE HYDROCHLORIDEVENLAFAXINE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORALEQ 150MG BASENoNo
003VENLAFAXINE HYDROCHLORIDEVENLAFAXINE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORALEQ 225MG BASENoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
70518-3136VENLAFAXINE HYDROCHLORIDEVENLAFAXINE HYDROCHLORIDEREMEDYREPACK INC.ANDACurrent
70518-3136VENLAFAXINE HYDROCHLORIDEVENLAFAXINE HYDROCHLORIDEREMEDYREPACK INC.ANDACurrent
71209-087VenlafaxineVenlafaxineCadila Pharmaceuticals LimitedANDACurrent
71209-087VenlafaxineVenlafaxineCadila Pharmaceuticals LimitedANDACurrent
71209-087VenlafaxineVenlafaxineCadila Pharmaceuticals LimitedANDACurrent
71209-088VenlafaxineVenlafaxineCadila Pharmaceuticals LimitedANDACurrent
71209-088VenlafaxineVenlafaxineCadila Pharmaceuticals LimitedANDACurrent
71209-088VenlafaxineVenlafaxineCadila Pharmaceuticals LimitedANDACurrent
71209-089VenlafaxineVenlafaxineCadila Pharmaceuticals LimitedANDACurrent
71209-089VenlafaxineVenlafaxineCadila Pharmaceuticals LimitedANDACurrent
71209-089VenlafaxineVenlafaxineCadila Pharmaceuticals LimitedANDACurrent
75834-217VENLAFAXINE HYDROCHLORIDEVENLAFAXINE HYDROCHLORIDENivagen Pharmaceuticals, Inc.ANDACurrent
75834-217VENLAFAXINE HYDROCHLORIDEVENLAFAXINE HYDROCHLORIDENivagen Pharmaceuticals, Inc.ANDACurrent
75834-218VENLAFAXINE HYDROCHLORIDEVENLAFAXINE HYDROCHLORIDENivagen Pharmaceuticals, Inc.ANDACurrent
75834-218VENLAFAXINE HYDROCHLORIDEVENLAFAXINE HYDROCHLORIDENivagen Pharmaceuticals, Inc.ANDACurrent
75834-219VENLAFAXINE HYDROCHLORIDEVENLAFAXINE HYDROCHLORIDENivagen Pharmaceuticals, Inc.ANDACurrent
75834-219VENLAFAXINE HYDROCHLORIDEVENLAFAXINE HYDROCHLORIDENivagen Pharmaceuticals, Inc.ANDACurrent